Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation

Robby Nieuwlaat; Alessandro Capucci; G Y H Lip; Shannon B. Olsson; Martin H. Prins; F. H. M. Nieman; José López‐Sendón; Panos Vardas; E Aliot; M. Santini; Harry J.G.M. Crijns

doi:10.1093/eurheartj/ehl015

Abstract

Antithrombotic therapy in AF is hardly tailored to the patient's stroke risk profile. Factors other than well-known stroke risk factors were significantly involved in antithrombotic management decisions. To facilitate this tailored treatment, guideline writers and physician educators should focus on providing one uniform and easy to use stroke risk stratification scheme.

Keywords

MedicineAntithromboticAtrial fibrillationStroke (engine)Medical prescriptionGuidelineInternal medicineCardiologyFibrinolytic agentIntensive care medicinePhysical therapyPharmacology

Affiliated Institutions

Related Publications

Oral Antithrombotic Agents for the Prevention of Stroke in Nonvalvular Atrial Fibrillation

Pooja Khatri , Ron Neyens , Mintu P. Turakhia +5 more

T he rate of stroke among adults with atrial fibrilla- tion (AF) varies widely, ranging between 1% and 20% annually (mean 4.5% per year) depending on comorbidities and a patient...

2012 Stroke 269 citations

Additive Role of Plasma von Willebrand Factor Levels to Clinical Factors for Risk Stratification of Patients With Atrial Fibrillation

Gregory Y.H. Lip , Deirdre A. Lane , Carl van Walraven +1 more

Background and Purpose— To aid decisions for thromboprophylaxis in atrial fibrillation (AF), several risk stratification schemes that predict stroke risk according to clinical a...

2006 Stroke 156 citations

Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation

Alexander C. Perino , Jun Fan , Mariam Askari +6 more

Background: Device-detected atrial fibrillation (AF) is associated with increased risk of stroke; however, there are no clearly defined thresholds of AF burden at which to initi...

2019 Circulation 104 citations

Prevalence of atrial fibrillation and eligibility for anticoagulants in the community

M. Sudlow , Richard Thomson , Barnaby Thwaites +2 more

Anticoagulants are effective in the prevention of stroke in atrial fibrillation and flutter (AF). We aimed to find out the prevalence of AF in the UK and to estimate the proport...

1998 The Lancet 384 citations

Prevalence, Age Distribution, and Gender of Patients With Atrial Fibrillation

William M. Feinberg

The prevalence of atrial fibrillation (AF) is related to age. Anticoagulation is highly effective in preventing stroke in patients with AF, but the risk of hemorrhage may be inc...

1995 Archives of Internal Medicine 2171 citations

Publication Info

Year: 2006
Type: article
Volume: 27
Issue: 24
Pages: 3018-3026
Citations: 371
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

371

OpenAlex

Cite This

APA Style

                            
                                
                                    Robby Nieuwlaat, 
                                
                                    Alessandro Capucci, 
                                
                                    G Y H Lip
                                
                                et al.
                            
                            (2006). 
                            Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. 
                            European Heart Journal
                            , 27
                            (24)
                            , 3018-3026.
                            https://doi.org/10.1093/eurheartj/ehl015
                        

Identifiers

DOI: 10.1093/eurheartj/ehl015